Abstract
The pharmacist’s role places them squarely on the front line of the benefit-risk analysis of drug administration. They are often the ones who explain the drugs to the patients and, in the process, supply part of the information about which patients must make an informed decision about their chemotherapy. This chapter presents the reflections of one oncology/pain specialty pharmacist.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology™— http://www.nccn.org/professionals/physician_gls/about.asp (last accessed July 2, 2009).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Clark-Vetri, R. (2010). Oncology Pharmacist’s Perspective. In: Raffa, R.B., Tallarida, R.J. (eds) Chemo Fog. Advances in Experimental Medicine and Biology, vol 678. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6306-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6306-2_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6305-5
Online ISBN: 978-1-4419-6306-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)